Baku 24° C
COVID vaccine manufacturers to make billions from selling third dose
Business
- 26 September, 2021
- 07:43
Pfizer may receive $26 billion from the sales of the third dose of its coronavirus vaccine in 2022, Report informs with reference to the Morningstar financial company.
The company's sales forecast for this year is $4 billion.
Another vaccine maker, Moderna, might earn $2 billion this year and $14 billion next year.
At the same time, Morningstar analysts believe that sales might increase significantly next year as countries approve the third dose.
Author
Latest News
23:56
UAE eyes new port to reduce reliance on Strait of Hormuz
Other countries23:44
Trump says US to charge 20% fee for securing Strait of Hormuz shipments
Other countries23:31
Zelenskyy awards Macron Ukraine's Order of Freedom
Other countries23:23
Photo
President Ilham Aliyev attended opening of 4th Shusha Global Media Forum - UPDATED
Media22:53
Hungarian parliament backs amendment to remove president
Other countries22:41
Three children among four killed in Syria ferry accident
Other countries22:26
Finland summons Russian ambassador over cyberattack allegations
Other countries22:04
Slovak president arrives in Azerbaijan for official visit
Foreign policy21:56